GlassScriptPhysician profile
Alayna Checkley
NPI 1508380858
$3,395.98
in general payments reported to CMS, 2019-2025
27 companies · $466 in 2025
The $466 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,436 · 2022: $617 · 2023: $394 · 2024: $483 · 2025: $466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,032.77 | 2021 | |
| Abbvie INC. | $459.80 | 2022-2025 | |
| Collegium Pharmaceutical, INC. | $392.95 | 2021-2025 | Belbuca, Xtampza |
| Teva Pharmaceuticals USA, INC. | $191.74 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $145.72 | 2023-2025 | Horizant, Horizant |
| Pfizer INC. | $142.38 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $119.15 | 2022 | |
| Nevro Corp. | $113.95 | 2022 | |
| Arbor Pharmaceuticals, INC. | $81.16 | 2021-2022 | |
| Lilly USA, LLC | $70.04 | 2022-2023 | Emgality, Reyvow |
| Vertex Pharmaceuticals Incorporated | $61.42 | 2024-2025 | |
| Lundbeck LLC | $57.31 | 2025 | Vyepti |
| Averitas Pharma INC. | $57.06 | 2024-2025 | Qutenza |
| Ferring Pharmaceuticals INC. | $56.38 | 2021-2025 | Euflexxa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.97 | 2022-2023 | Relistor |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $47.83 | 2022 | |
| Globus Medical, INC. | $45.00 | 2025 | Senza |
| Upsher-Smith Laboratories LLC | $42.80 | 2021 | |
| Almatica Pharma LLC | $38.68 | 2021 | |
| Scilex Pharmaceuticals INC. | $30.46 | 2021 | |
| Allergan, INC. | $29.30 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $27.66 | 2021 | |
| Axsome Therapeutics, INC. | $23.52 | 2025 | Symbravo |
| Boston Scientific Corporation | $21.99 | 2025 | Artisan |
| Spr Therapeutics, INC | $18.08 | 2023 | Sprint Pns System |
| Amgen INC. | $17.87 | 2022 | |
| Medtronic, INC. | $15.99 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alayna Checkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.